Sumary of EU drug agency denies already finding causal link between AstraZeneca vaccine and blood clots:
- Europe drug regulator has denied it has already established a causal connection between the Oxford/AstraZeneca vaccine and a rare blood clotting syndrome, after a senior official from the agency said there was a link..
- In a statement to Agence France-Presse, the European Medicines Agency (EMA) said on Tuesday it had “not yet reached a conclusion and the review is currently ongoing”, adding that it expected to announce its findings on Wednesday or Thursday..
- Marco Cavaleri, the EMA head of vaccines, had earlier told Italy Il Messaggero newspaper that in his opinion “we can say it now, it is clear there is a link with the vaccine … But we still do not know what causes this reaction.”.
- Concerns over rare but serious blood clotting events in a small number of recipients have dogged the shot in recent weeks, with more than a dozen European countries briefly suspending its use last month pending an EMA investigation..
- The World Health Organization, EMA and Medicines and Healthcare products Regulatory Agency (MHRA) have all said people should continue taking it because the benefits in preventing Covid-19 infection and its complications continued to far outweigh any risks..
- Most countries have since resumed inoculation with the AstraZeneca shot, but several – including France, Germany, Italy, France, Spain, the Netherlands and Canada – have suspended its administration in people aged under 55, 60 or 65..
- The EMA is looking into 14 deaths among recipients of the jab that had been reported by 22 March and are related to unusual blood clots in the brain, known as cerebral venous sinus thrombosis (CVST), accompanied by a low platelet count..
- “Among the vaccinated, there are more cases of cerebral thrombosis … among young people than we would expect.”…